Short answer: Cavaliers carry one of the highest inherited heart risks of any breed. About half have a mitral valve murmur by age 5 and nearly all by age 10, according to the Universities Federation for Animal Welfare (UFAW). Early on, the cost is yearly screening and the occasional X-ray or echocardiogram. Once a dog needs daily heart medication, PetMD puts the drugs alone at roughly $100–300 a month. Insuring before any murmur is recorded is the key to having it covered.
Cavalier King Charles Spaniels carry one of the most well-documented breed-specific health risks in veterinary medicine: a very high lifetime rate of mitral valve disease that appears years earlier than in other breeds. For this breed, insurance timing and heart-focused budgeting deserve more attention than general pet-cost planning.
How Common Is Heart Disease in Cavaliers?
Very. UFAW’s summary of the research says myxomatous mitral valve disease (MVD) is about 20 times more common in Cavaliers than in other breeds. Murmurs typically appear at three to four years in males and four to five in females, compared with six to seven in other susceptible breeds. The ACVIM consensus guidelines — the reference veterinary cardiologists use — also note that Cavaliers develop the disease at a relatively young age. Once it starts, though, it doesn’t progress to heart failure noticeably faster than in other small breeds.
That gives owners a long runway. Many Cavaliers live with a mild murmur for years before needing treatment. UFAW notes a life-threatening stage may be reached within one to three years of diagnosis, and once severe heart failure sets in, survival has averaged about seven months. For how common heart disease is across older dogs generally, see senior dog heart disease statistics.
What Do the Stages Mean for Your Budget?
Vets stage MVD using the ACVIM system. Here’s roughly what each stage involves and what drives the cost:
| ACVIM stage | What it means | Typical care | Main costs |
|---|---|---|---|
| A | At-risk breed, no murmur yet | Yearly heart check at the routine exam | Exam fee |
| B1 | Murmur, heart not significantly enlarged | Imaging to stage it, then periodic rechecks | Echocardiogram and/or X-rays |
| B2 | Murmur with an enlarged heart, no symptoms | Pimobendan usually recommended; closer monitoring | Daily medication + rechecks |
| C | Current or past heart failure | Several daily drugs (e.g., pimobendan, diuretics) | Medication, frequent rechecks, possible emergency care |
| D | Heart failure that no longer responds to standard treatment | Intensive, specialist-led care | Hospital stays, specialist visits |
Key price points from sources we checked:
- Chest X-rays: a national average of about $213 (range $169–388), per CareCredit’s 2025 cost study. PetMD notes dogs in earlier stages commonly need checkups every six months and yearly chest X-rays.
- Echocardiogram: the test that confirms and stages MVD, usually done by a veterinary cardiologist. Specialist fees vary widely by region, so ask for a written estimate.
- Medication once treatment starts: roughly $100–300 a month depending on weight, according to PetMD. Cavaliers are small, which helps keep doses — and costs — toward the lower end.
Is Early Medication Worth It?
For dogs at stage B2, the evidence is strong. In the EPIC trial, a randomized study of 360 dogs with enlarged hearts from MVD, the median time to heart failure or cardiac death was 1,228 days with pimobendan versus 766 days with placebo — roughly 15 extra months — and treated dogs lived longer overall. The ACVIM guidelines recommend pimobendan at this stage. It isn’t recommended for every dog with a murmur, which is why imaging to confirm the stage matters.
Other Costs Worth Budgeting For
Heart disease isn’t the only breed-specific expense. UFAW’s review of syringomyelia, a painful spinal-cord condition, reports it in 25% of one-year-old and 70% of six-year-old Cavaliers screened by MRI. Diagnosis needs an MRI under anesthesia, which CareCredit puts at a national average of $2,285 (range $1,811–4,140). UFAW lists signs such as yelping after sudden changes in posture (like being picked up), uncontrollable scratching at the ears, neck and shoulders, and sensitivity to touch around the neck. See your vet if you notice them.
How Should Owners Plan Financially for This Breed’s Heart Risk?
- Insure as early as possible, ideally as a puppy and before any vet has recorded a murmur. A murmur noted before coverage starts or during the waiting period will almost certainly be excluded — see does pet insurance cover pre-existing conditions.
- Choose a policy that covers hereditary conditions and has room for long-term treatment. A chronic heart condition is exactly where a low annual or per-condition cap runs out — see annual limit vs. per-incident pet insurance.
- Budget for yearly cardiac screening as standard care, not an extra. UFAW recommends screening every Cavalier for murmurs once a year from age one.
- Set aside a fund for long-term medication and rechecks, since MVD management is ongoing, not a one-off bill.
- Ask your vet for a written cost plan once a murmur is found, covering how often imaging will be repeated and what medication would cost for your dog’s weight.
For context on premiums, the average US accident-and-illness policy for dogs cost $836 a year (about $70 a month) in 2025, according to the North American Pet Health Insurance Association; breed, age and ZIP code move that number. See dog insurance cost per month and how premiums differ by breed.
When to See the Vet Right Away
Contact your vet the same day if a Cavalier with a known murmur starts breathing faster or with more effort, coughs, can’t settle comfortably, tires after little effort, loses appetite, or collapses or faints. PetMD lists these as signs of more advanced mitral valve disease, and fluid building up in the lungs means the dog has moved into heart failure.
This article is for informational purposes only and does not replace guidance from your veterinarian. Costs are indicative US figures; this is general information, not insurance or financial advice.
Sources
- Universities Federation for Animal Welfare — Cavalier King Charles Spaniel: Mitral Valve Disease, May 2026
- Universities Federation for Animal Welfare — Cavalier King Charles Spaniel: Syringomyelia, May 2026
- Keene BW et al. — ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs, Journal of Veterinary Internal Medicine, 2019
- Boswood A et al. — Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study, Journal of Veterinary Internal Medicine, 2016
- PetMD — Mitral Valve Disease in Dogs, January 2026
- CareCredit — X-ray cost for dogs and Dog MRI cost, 2026
- North American Pet Health Insurance Association — State of the Industry Report 2026, June 2026
